Intel 570% Past Year: Buy the Comeback or Take Profits?
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
Different volatility measures reveal different risk facets of stock indices. This primer clarifies what each metric means for decisions.
23,218 articlesIntel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Workday delivered a stronger-than-expected earnings beat, but the market fixated on AI-driven demand shifts that coul...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
With $1,000, you can start building a reliable dividend income stream. This guide explains what best dividend stocks ...
In a landmark move, australia’s richest person just disclosed a stake worth more than $1 billion in SpaceX as the pri...
A shift toward a more hawkish Fed path can reshape how we value large banks. This guide breaks down the math, expecta...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
As butterfly (BFLY) prepares for 2025 earnings, investors want clarity on growth, margins, and cash runway. This arti...